Medtronic plc

NYSE:MDT

90.07 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989198819871986
Revenue 32,36431,22731,68630,11728,91330,55729,95329,71028,83320,26117,00516,59016,18415,93315,81714,59913,51512,29911,29210,054.69,087.27,665.26,410.85,551.85,014.64,134.12,604.82,438.22,169.11,742.41,390.91,328.21,176.91,021.4836.6741.7653.3502402.8
Cost of Revenue 12,91110,71910,14510,4839,4249,1559,0559,2919,1426,3094,3334,1263,8893,9123,8123,5183,4463,1682,815.32,446.42,252.91,890.31,652.71,113.31,076.3889.7532.8493.3477.9433.6353.1350.5322.4285.2232.4194.4181142.8117.5
Gross Profit 19,45320,50821,54119,63419,48921,40220,89820,41919,69113,95212,67212,46412,29512,02112,00511,08110,0699,1318,476.77,608.26,834.35,774.94,758.14,438.53,938.33,244.42,0721,944.91,691.21,308.81,037.8977.7854.5736.2604.2547.3472.3359.2285.3
Gross Profit Ratio 0.6010.6570.680.6520.6740.70.6980.6870.6830.6890.7450.7510.760.7540.7590.7590.7450.7420.7510.7570.7520.7530.7420.7990.7850.7850.7950.7980.780.7510.7460.7360.7260.7210.7220.7380.7230.7160.708
Reseach & Development Expenses 2,7352,6962,7462,4932,3312,3302,2532,1932,2241,6401,4771,5571,4901,5081,4831,3551,2751,2391,112.9951.3851.5749.4646.3577.6479.7429.2297.2280.2236.7191.4156.300000000
General & Administrative Expenses 000000000000000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000000000000000
SG&A 10,62210,41510,29210,14810,10910,4189,9749,7119,4696,9045,8475,6986,0745,5335,7895,1524,7074,1533,659.43,213.62,801.42,371.91,962.81,685.21,587.91,280.1757.6763.3695.6574.6470.3613549.1483.3399.8373313.2227.1185.7
Other Expenses -3641,5672,5952,0981,8273732,3282,2022,0388515304393354594683960000000297.3243.3213.1137.6116.9111.8106.578.669.659.446.539.444.62926.423.3
Operating Expenses 13,72114,67815,63314,73914,26714,77014,55514,10613,7319,3957,8547,6947,8997,0417,7406,9035,9825,3924,772.34,164.93,652.93,121.32,609.12,560.12,310.91,922.41,192.41,160.41,044.1872.5705.2682.6608.5529.8439.2417.6342.2253.5209
Operating Income 5,7325,4855,7524,4844,7916,2686,6515,3305,2913,7664,0844,6394,6964,1734,3712,8112,8853,5153,161.32,543.52,796.92,341.31,524.21,549.41,629822702809.2668.4442.1346.8299.1242.9196.3159.9150.3131.1108.777.7
Operating Income Ratio 0.1770.1760.1820.1490.1660.2050.2220.1790.1840.1860.240.280.290.2620.2760.1930.2130.2860.280.2530.3080.3050.2380.2790.3250.1990.270.3320.3080.2540.2490.2250.2060.1920.1910.2030.2010.2170.193
Total Other Income Expenses Net -895-121-235-589-736981-983-669-791-1,005-368-102-979-50-1,555-1,311-378-630.5-944.9-387.3-305.1-618.2-403.2-13.8-471.2-169.53429.214.822.328.810.33.65296.7719.5
Income Before Tax 4,8375,3645,5173,8954,0555,1975,6754,6024,3363,4863,7054,2514,1453,7233,9692,5942,8853,5153,161.32,543.52,796.92,341.31,524.21,549.41,629822702809.2668.4442.1346.8313.5242.9196.3159.9150.3131.1108.791.7
Income Before Tax Ratio 0.1490.1720.1740.1290.140.170.1890.1550.150.1720.2180.2560.2560.2340.2510.1780.2130.2860.280.2530.3080.3050.2380.2790.3250.1990.270.3320.3080.2540.2490.2360.2060.1920.1910.2030.2010.2170.228
Income Tax Expense 1,1331,580456265-7515472,580578798811640784730627870425654713614.6739.6837.6741.5540.2503.4530.5353.6244.6279.2230.6148.1114.4101.981.462.951.252.944.634.924.3
Net Income 3,6763,7585,0393,6064,7894,6313,1044,0283,5382,6753,0653,4673,6173,0963,0992,1692,2312,8022,546.71,803.91,959.31,599.89841,0461,098.5468.4457.4530437.8294232.4197.2161.5133.4108.797.486.573.853.4
Net Income Ratio 0.1140.120.1590.120.1660.1520.1040.1360.1230.1320.180.2090.2230.1940.1960.1490.1650.2280.2260.1790.2160.2090.1530.1880.2190.1130.1760.2170.2020.1690.1670.1480.1370.1310.130.1310.1320.1470.133
EPS 2.772.833.752.683.573.442.292.922.512.443.063.43.432.872.81.851.972.442.111.491.611.310.810.870.910.40.520.510.450.320.250.210.170.140.120.110.10.090.06
EPS Diluted 2.762.823.732.663.543.412.272.892.482.413.023.373.412.862.791.841.952.412.091.481.61.30.80.850.890.390.510.50.450.320.250.210.170.140.120.110.10.090.06
EBITDA 8,3799,0428,9327,9338,2419,6649,3849,5969,2116,2496,6735,9575,2586,7635,0375,0656,0354,7004,878.54,851.54,011.33,366.83,0972,578.91,884.52,006.31,186.7867.4729.7528388.9335.9295.1249.3199.4145.3152.4125.180.1
EBITDA Ratio 0.2590.290.2820.2630.2850.3160.3130.3230.3190.3080.3920.3590.3250.4240.3180.3470.4470.3820.4320.4830.4410.4390.4830.4650.3760.4850.4560.3560.3360.3030.280.2530.2510.2440.2380.1960.2330.2490.199